EUVIMEDEUVIMED entdecken
Crossref

Assessing Liver Viability: Insights From Mitochondrial Bioenergetics in Ischemia-Reperfusion Injury

Chinedu Nwaduru, Emma Baker, Michelle Buff, Motaz Selim, Leo Aviles Ovalle, Talia B Baker, Michael A Zimmerman

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2023.11.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Chinedu Nwaduru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Transplantation and Advanced Hepatobiliary Surgery, University of Utah School of Medicine, Salt Lake City, Utah. E…. Hauptthemen laut MEDLINE: Organ Preservation, Reperfusion Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthotopic liver transplantation remains the definitive treatment for patients with end-stage liver disease. Unfortunately, the increasing demand for donor livers and the limited supply of viable organs have both led to a critical need for innovative strategies to expand the pool of transplantable organs. The mitochondrion, central to hepatic cellular function, plays a pivotal role in hepatic ischemic injury, with impaired mitochondrial function and oxidative stress leading to cell death. Mitochondrial protection strategies have shown promise in mitigating IRI and resuscitating marginal organs for transplant. Machine perfusion (MP) has been proven a valuable tool for reviving marginal organs with very promising results. Evaluation of liver viability during perfusion traditionally relies on parameters including lactate clearance, bile production, and transaminase levels. Nevertheless, the quest for more comprehensive and universally applicable viability markers persists. Normothermic regional perfusion has gained robust attention, offering extended recovery time for organs from donation after cardiac death donors. This approach has shown remarkable success in improving organ quality and reducing ischemic injury using the body's physiological conditions. The current challenge lies in the absence of a reliable assessment tool for predicting graft viability and post-transplant outcomes. To address this, exploring insights from mitochondrial function in the context of ischemia-reperfusion injury could offer a promising path toward better patient outcomes and graft longevity. Indeed, hypoxia-induced mitochondrial injury may serve as a surrogate marker of organ viability following oxygenated resuscitation techniques in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organ PreservationReperfusion InjuryHumansLiverIschemiaEnergy MetabolismMitochondriaPerfusion

Autor:innen und Institutionen

  • Department of Surgery, Division of Transplantation and Advanced Hepatobiliary Surgery, University of Utah School of Medicine, Salt Lake City, Utah. Electronic address: chinedu.nwaduru@hsc.utah.edu.
  • Department of Surgery, Division of Transplantation and Advanced Hepatobiliary Surgery, University of Utah School of Medicine, Salt Lake City, Utah.

Zitieren

APA

Nwaduru, C., Baker, E., Buff, M., Selim, M., Ovalle, L. A., Baker, T. B., & Zimmerman, M. A. (2024). Assessing Liver Viability: Insights From Mitochondrial Bioenergetics in Ischemia-Reperfusion Injury. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.11.019

Vancouver

Nwaduru C, Baker E, Buff M, Selim M, Ovalle LA, Baker TB, et al. Assessing Liver Viability: Insights From Mitochondrial Bioenergetics in Ischemia-Reperfusion Injury. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2023.11.019

BibTeX
@article{Nwaduru2024,
  author = {Nwaduru, Chinedu and Baker, Emma and Buff, Michelle and Selim, Motaz and Ovalle, Leo Aviles and Baker, Talia B and Zimmerman, Michael A},
  title = {Assessing Liver Viability: Insights From Mitochondrial Bioenergetics in Ischemia-Reperfusion Injury},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2023.11.019}
}
Kostenlos starten →